1. Clinical relevance of the single-lead ECG of the Apple Watch. (3rd October 2022) Authors: Pepplinkhuizen, S; Hoeksema, W F; Van Der Stuijt, W; Smeding, L; Wilde, A A M; Knops, R E Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical relevance of the single-lead ECG of the Apple Watch. Issue 4 (22nd December 2022) Authors: Pepplinkhuizen, S; Hoeksema, W F; Van Der Stuijt, W; Smeding, L; Wilde, A A M; Knops, R E Journal: European heart journal Issue: Volume 3:Issue 4(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Defibrillation success after subcutaneous implantable cardioverter-defibrillator generator replacement is not affected by impedance increase. (24th May 2021) Authors: Van Der Stuijt, W; Pepplinkhuizen, S; Quast, ABE; Smeding, L; Olde Nordkamp, LRA; Wilde, AAM; Knops, RE Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Exercise-optimized programming after S-ICD implantation contributes to a lower risk of inappropriate shocks in the latest generation S-ICDs. (24th May 2021) Authors: Pepplinkhuizen, S; Van Der Stuijt, W; Kooiman, KM; Quast, A-F BE; Oosterwerff, FJ; Smeding, L; Olde Nordkamp, LRA; Delnoy, P-P HM; Wilde, AAM; Knops, RE Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long-term follow-up of paediatric patients with a subcutaneous implantable cardioverter-defibrillator. (25th November 2020) Authors: Van Der Stuijt, W; De Wilde, K.C; Baalman, S.W.E; Quast, A.B.E; Blom, N.A; Wilde, A.A.M; Knops, R.E Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Mechanism, follow-up and recurrence of inappropriate therapy in the PRAETORIAN trial: action reduces recurrence. (19th May 2022) Authors: Pepplinkhuizen, S; Delnoy, PPHM; Olde Nordkamp, LRA; Kuschyk, J; Bonnemeier, H; Bijsterveld, NR; Boersma, LVA; El-Chami, MF; Smeding, L; Van Der Stuijt, W; De Weger, A; Richter, S; Betts, TR; Wilde, AAM; Knops, RE Journal: Europace Issue: Volume 24:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Reasons for replacement and extraction of the subcutaneous implantable cardioverter-defibrillator in a large cohort. (19th May 2022) Authors: Van Der Stuijt, W; Pepplinkhuizen, S; Smeding, L; Olde Nordkamp, LRA; Wilde, AAM; Knops, RE Journal: Europace Issue: Volume 24:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The eligibility of patients with an inherited cardiac disease for therapy with a subcutaneous implantable cardioverter-defibrillator. (3rd October 2022) Authors: Proost, V M; Van Der Stuijt, W; Pepplinkhuizen, S; Knops, R E; Wilde, A A M Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗